jpmorgan chinese investment trust: annual general meeting chin… · lin he industrials / consumer...
TRANSCRIPT
JPMorgan Chinese Investment Trust: Annual General Meeting
January 2018
Howard Wang , Managing Director Portfolio Manager and Head of the Greater China Equities Team
Rebecca Jiang , Executive DirectorPortfolio Manager
1 | INVESTMENT INVOLVES RISK. PLEASE REFER TO THE OFF ERING DOCUMENT(S) FOR DETAILS, INCLUDING THE RISK FACTORS
Questions from investors
� What’s the impact of the deleveraging? What’s your take on the policy landscape in China?
� Given the rally this year, are we at the top of the valuation cycle? Should we sell?
� How should we think about A-shares?
� Besides tech, where are the opportunities?
2 | INVESTMENT INVOLVES RISK. PLEASE REFER TO THE OFF ERING DOCUMENT(S) FOR DETAILS, INCLUDING THE RISK FACTORS
The 19th Party Congress shows political maturity and should reinforce existing trends
The opinions and views expressed here are those held by the author at the date of publication which are subject to change and are not to be taken as or construed as investment advice.
Primary takeaways• Enhanced ability of the central government on policy execution
• Focus on the quality - not just quantity - of economic growth
Primary implications
• De-risking : of the financial system, of the stress on the environment, of the real estate market
• Optimization of the economic growth model : a long-standing goal to move away from investment and towards consumption
… supportive of a lower cost of capital and, eventua lly, the performance of growth and income equities (especially those within New China)
3 | INVESTMENT INVOLVES RISK. PLEASE REFER TO THE OFF ERING DOCUMENT(S) FOR DETAILS, INCLUDING THE RISK FACTORS
Limited spillover from credit growth being curbedLimited spillover from credit growth being curbed
Slower growth in China amidst long overdue structur al adjustments domestically…
Source: Morgan Stanley Research, Bloomberg, People’s Bank of China. Data as of end Oct 2017 ^ Numbers shown are aggregate of Beijing, Tianjin and Hebei. Source: CICC. Data as of 31 Oct 2017
-4%
-2%
0%
2%
4%
6%
8%
10%
12%
14%
0%
2%
4%
6%
8%
10%
12%
14%
03/16 06/16 09/16 12/16 03/17 06/17 09/17
Fixed Asset Investment YoY (%) - LHS
Power Utilization YoY (%) - RHS
Impact of environmental control measures^Impact of environmental control measures^
5.0%
5.5%
6.0%
6.5%
7.0%
7.5%
10%
12%
14%
16%
18%
20%
22%
24%
26%
28%
03/14 09/14 03/15 09/15 03/16 09/16 03/17 09/17
YoY Growth (%) of Monthly Domestic Credits - LHS
General Loan Rate (%) - RHS
4 | INVESTMENT INVOLVES RISK. PLEASE REFER TO THE OFF ERING DOCUMENT(S) FOR DETAILS, INCLUDING THE RISK FACTORS
0
50
100
150
200
250
300
07 08 09 10 11 12 13 14 15 16 17
MSCI ChinaNew ChinaOld China
….but it should not impair the corporate earnings of “New China” equities
New China = Information Technology, Consumer, HealthcareOld China = Energy, Materials, IndustrialsSource: Factset, Morgan Stanley Research, J.P. Morgan Asset Management. Data available as of 31 December 2017.Indices do not include fees or operating expenses and are not available for actual investment. Past performance is not necessarily a reliable indicator for current and future performance.
Year end 2007 rebased to 100
Earnings per share trends reflect that structural trumps cyclicalEarnings per share trends reflect that structural trumps cyclical
And a similar story is told by return on equity…And a similar story is told by return on equity…
0%
5%
10%
15%
20%
25%
09 10 11 12 13 14 15 16 17
MSCI China
New China
Old China
5 | INVESTMENT INVOLVES RISK. PLEASE REFER TO THE OFF ERING DOCUMENT(S) FOR DETAILS, INCLUDING THE RISK FACTORS
Valuations remain reasonable
PE = Price to Earnings RatioPB = Price to Book RatioSource: Thomson Reuters Datastream, Bloomberg. As of 31st December 2017.Indices do not include fees or operating expenses and are not available for actual investment.Past performance is not a reliable indicator of current and future performance.
Trailing PBTrailing PB12-Month Forward PE12-Month Forward PE
x x
0
5
10
15
20
25
30
35
4/06 4/08 4/10 4/12 4/14 4/16
CSI 300Average: 14.1xCurrent: 13.7x
0
1
2
3
4
5
6
7
4/06 4/08 4/10 4/12 4/14 4/16
CSI 300Average: 2.2xCurrent: 2.0x
MSCI ChinaAverage: 2.1xCurrent: 2.0x
MSCI ChinaAverage: 11.5xCurrent: 13.5x
6 | INVESTMENT INVOLVES RISK. PLEASE REFER TO THE OFF ERING DOCUMENT(S) FOR DETAILS, INCLUDING THE RISK FACTORS
China25.6
China A13.7
China29.5
China A0.8
China29.7
China’s liberalization progress has led to MSCI’s in clusion of A-shares in its indices…
*Based on free float market-cap of 230 A-share stocks to be included, and a 30% upper limit of foreign ownership.Source: (Top) WIND and Citi Research. Data as of end November 2017. (Bottom) MSCI Consultation on China A-Shares Potential Inclusion, June 2017. EM = Emerging Markets
Roadmap for A-share inclusion in the MSCI EM IndexRoadmap for A-share inclusion in the MSCI EM Index
ChinaWeight29.7%
ChinaWeight30.3%
ChinaWeight39.3%
Weight of MSCI EM (Current) First inclusion step : May 2018Second inclusion step: Aug 2018
(5% inclusion factor for 230 A-shares)By 2025*
(100% inclusion factor for 230 A-shares)
0.0%0.5%1.0%1.5%2.0%2.5%3.0%3.5%
01/16 03/16 05/16 07/16 09/16 11/16 01/17 03/17 05/17 07/17 09/17 11/17
Stock Connect Northbound Trading Value as % of A-sh are TotalStock Connect Northbound Trading Value as % of A-sh are Total
7 | INVESTMENT INVOLVES RISK. PLEASE REFER TO THE OFF ERING DOCUMENT(S) FOR DETAILS, INCLUDING THE RISK FACTORS
We are positioned towards long term structural grow th opportunities
Healthcare
Technology
and
Automation
Consumption
Technology� Mobility device functionality
upgrades� Surveillance solutions� Factory automation
Consumption Upgrade� Household durables� Food & beverages� Leisure & entertainment� Education
Healthcare� Innovative drug R&D� Traditional Chinese medicine� Healthcare services
8 | INVESTMENT INVOLVES RISK. PLEASE REFER TO THE OFF ERING DOCUMENT(S) FOR DETAILS, INCLUDING THE RISK FACTORS
Stock example: BOE Technology (A-share, information technology)
Source: J.P. Morgan Asset Management. Updated as of end November 2017. The companies above are shown for illustrative purposes only. Their inclusion should not be interpreted as a recommendation to buy or sell.
Market leader in China with significant market share in TFT-LCD
Economics
� Strong top-line and return on equity
� Key supplier to TV brands including Samsung, LG & Sony
� World class cost structure on LCDs
Duration
� China taking market share from Korea and Taiwan in flat panel displays, with BOE in dominant position
� Excellent R&D capabilities: currently owns over 50,000 usable patents
Governance
� Minority interests protected by independent directors and the supervisory board
Favourable market environment with excellent growth prospectFavourable market environment with excellent growth prospect
9 | INVESTMENT INVOLVES RISK. PLEASE REFER TO THE OFF ERING DOCUMENT(S) FOR DETAILS, INCLUDING THE RISK FACTORS
0%
2%
4%
6%
8%
10%
12%
14%
16%
18%
0
10,000
20,000
30,000
40,000
50,000
60,000
70,000
80,000
90,000
100,000
2010
A
2011
A
2012
A
2013
A
2014
A
2015
A
2016
E
2017
E
2018
E
2019
E
2020
E
2021
E
China oncology market (in RMB mn, LHS)
Market share
Leading position in China’s oncology marketLeading position in China’s oncology market
Stock example: Jiangsu Hengrui Medicine (A-share, h ealthcare)
Source: R&D = Research and Development; PDB (China Prescription Sales Database), J.P. Morgan Asset Management, as of 25 Jan 2017.
The companies above are shown for illustrative purposes only. Their inclusion should not be interpreted as a recommendation to buy or sell.
Opinions, estimates, forecasts, projections and statements of financial market trends are based on market conditions at the date of the publication, constitute our judgment and are subject to change without notice. There can be no guarantee they will be met.
A deep pipeline of surgical anesthetics and oncology drugs with overseas expansion opportunities
Economics
� Superior R&D capabilities evidenced by strong sales of oncology drugs and surgical anesthetics
Duration
� Best positioned in oncology treatment market
� Structurally growing sector supported by demographics and rising healthcare spend
Governance
� Visionary management with disciplined capital allocation
10 | INVESTMENT INVOLVES RISK. PLEASE REFER TO THE OFF ERING DOCUMENT(S) FOR DETAILS, INCLUDING THE RISK FACTORS
15.9 15.9 16.0
16.4 16.4
16.9
16.6
17.9
2009 2010 2011 2012 2013 2014 2015 2016
Stock example: New Oriental Education (consumer dis cretionary)
Source: J.P. Morgan Asset Management, as of end June 2017The companies above are shown for illustrative purposes only. Their inclusion should not be interpreted as a recommendation to buy or sell.
Largest tutoring service provider in China
Accelerated growth of new born babies in ChinaAccelerated growth of new born babies in ChinaEconomics
� Solid track record in cash flow generation with a strong balance sheet
Duration
� Balanced portfolio with nationwide coverage, including K-12 tutoring, language training and test preparation courses
� A long-term beneficiary of 2nd Child Policy and GaokaoReform in China
Governance
� Experienced and committed management team with track record of dividend payouts and share buybacks
Source: gov.cn/xinwen/
MM+16.6%
Number of New Born Babies
11 | INVESTMENT INVOLVES RISK. PLEASE REFER TO THE OFF ERING DOCUMENT(S) FOR DETAILS, INCLUDING THE RISK FACTORS
JPMorgan Chinese Investment Trust Update
12 | INVESTMENT INVOLVES RISK. PLEASE REFER TO THE OFF ERING DOCUMENT(S) FOR DETAILS, INCLUDING THE RISK FACTORS
Penny TuInternet /ConsumerExperience: 12/4
Greater China Investment Professionals
Joiners and Leavers as of 31st December 2017. Number of years experience: Industry/Firm as of 31st December 2017
Richard TitheringtonHead of EMAP Equities TeamExperience: 34/32
James YehExperience: 22/16
Howard WangHead of Greater ChinaExperience: 23/13
Emerson YipExperience: 24/12
Lilian LeungExperience: 23/8
William TongCIO, TaiwanExperience: 24/10
China and Greater China Growth
Rebecca JiangExperience: 13/1
Greater China Team Portfolio Managers
Shumin HuangHead of Greater China ResearchExperience: 26/12
Bonnie ChangAutomobiles / IndustrialsExperience: 18/3
William ChenTechnology / IndustrialsExperience: 11/8
Robert YenTechnology / IndustrialsExperience: 15/2
Elizabeth PangDomestic HK / China IndustrialsExperience: 13/13
Greater China Team Research Analysts
Lin HeIndustrials / ConsumerExperience: 15/<1
Dong XuExperience: 15/1
Eva WangConsumerExperience: 13/1
Vincent YuHealthcare / IndustrialsExperience: 10/5
Connie Shen Financials / PropertyExperience: 7/4
Mark MaoIndustrials / ConsumerExperience: 8/1
Hong Kong and China Core and Value / Income
China Wholly Foreign-Owned Enterprise (WFOE)
Taiwan Growth
Select GEM Global and Sector Analysts
Andrew TanNatural ResourcesExperience: 23/10
Paul ChanTechnologyExperience: 24/18
Simmy QiIndustrialsExperience: 7/7
Denise ValentineBiotechnologyExperience: 22/2
Maciej WasilewiczFinancialsExperience: 10/3
George IwanickiEconomics/StrategyExperience: 30/26
13 | INVESTMENT INVOLVES RISK. PLEASE REFER TO THE OFF ERING DOCUMENT(S) FOR DETAILS, INCLUDING THE RISK FACTORS
Performance
Trust launch date = 19 Oct 1993.^ Dividends reinvested after deduction of withholding tax. Prior to 26 Jan 2016, MSCI Golden Dragon (NDR).Prior to 1 Jun 2002, MSCI Provisional Golden Dragon Index (NDR). Prior to 1 Oct 2001,Customised benchmark (Calculated by J.P. Morgan Asset Management and comprised 40% HSI, 40% Taiwan Weighted and 20% BNP Paribas China Price). Prior to 1 Oct 1998, BNP Paribas ChinaPrice.* Arithmetic excess return presented.Source: J.P. Morgan Asset Management. Performance data has been calculated on NAV to NAV basis, including ongoing charges and any applicable fees, with any income reinvested, in GBP. Pleasenote Benchmark Indices do not operating expenses and are not available for actual investment. Past performance is not necessarily a reliable indicator for current and futureperformance. Morningstar. As of end December 2017.Morningstar Ratings ™: © Morningstar. All Rights Reserved. The methodology and calculations used by companies that provide awards andratings are not verified by J.P. Morgan Asset Management and therefore are not warranted to be accurate or complete
JPMorgan Chinese Investment Trust as of 31st December 2017
Three months Six months One year Three years Five years Since launch
JPMorgan Chinese Investment Trust plc 12.48 23.69 53.82 21.15 17.98 6.82
MSCI China (NDR)^ 6.73 18.48 40.73 19.17 15.23 5.41
Excess return* 5.74 5.21 13.09 1.97 2.75 1.41
2010 2011 2012 2013 2014 2015 2016 2017
JPMorgan Chinese Investment Trust plc 20.38 -22.89 21.16 13.66 13.12 0.14 15.42 53.82
MSCI China (NDR)^ 16.80 -18.06 16.82 4.91 14.42 -2.07 22.81 40.73
Excess return* 3.58 -4.83 4.34 8.75 -1.30 2.21 -7.38 13.09
Annualised performance (%)
Calendar year performance (%)
Market value
JPMorgan Chinese Investment Trust GBP 254.2m
Market value
JPMorgan Chinese Investment Trust GBP 254.2m
3-Year
5-Year and 10-Year
Morningstar Overall RatingsTM
14 | INVESTMENT INVOLVES RISK. PLEASE REFER TO THE OFF ERING DOCUMENT(S) FOR DETAILS, INCLUDING THE RISK FACTORS
Performance
Trust launch date = 19 Oct 1993.^ Dividends reinvested after deduction of withholding tax. Prior to 26 Jan 2016, MSCI Golden Dragon (NDR).Prior to 1 Jun 2002, MSCI Provisional Golden Dragon Index (NDR). Prior to 1 Oct 2001,Customised benchmark (Calculated by J.P. Morgan Asset Management and comprised 40% HSI, 40% Taiwan Weighted and 20% BNP Paribas China Price). Prior to 1 Oct 1998, BNP Paribas ChinaPrice.* Arithmetic excess return presented.Source: J.P. Morgan Asset Management. Performance data has been calculated on NAV to NAV basis, including ongoing charges and any applicable fees, with any income reinvested, in GBP. Pleasenote Benchmark Indices do not operating expenses and are not available for actual investment. Past performance is not necessarily a reliable indicator for current and futureperformance. Morningstar. As of end December 2017.Morningstar Ratings ™: © Morningstar. All Rights Reserved. The methodology and calculations used by companies that provide awards andratings are not verified by J.P. Morgan Asset Management and therefore are not warranted to be accurate or complete
JPMorgan Chinese Investment Trust as of 31st December 2017
2010 2011 2012 2013 2014 2015 2016 2017
JPMorgan Chinese Investment Trust plc (Share Price) 16.8 -30.1 24.6 11.6 11.4 -4.7 15.4 57.1
JPMorgan Chinese Investment Trust plc (NAV) 20.4 -22.9 21.2 13.7 13.1 0.1 18.1 53.8
MSCI China Index (NDR)^ 16.8 -18.1 16.8 4.9 14.4 -2.1 22.8 40.7
Rolling 12 Months at Year Ends (%)
Market value
JPMorgan Chinese Investment Trust GBP 254.2m
Market value
JPMorgan Chinese Investment Trust GBP 254.2m
3-Year
5-Year and 10-Year
Morningstar Overall RatingsTM
15 | INVESTMENT INVOLVES RISK. PLEASE REFER TO THE OFF ERING DOCUMENT(S) FOR DETAILS, INCLUDING THE RISK FACTORS
19.1
16.4
15
16
17
18
19
20
Portfolio MSCI China
ROE (%)
40.5
33.4
0
5
10
15
20
25
30
35
40
45
Portfolio MSCI China
3-5 year EPS growth (%)
Current position is geared towards structural growt h
ROE = Return on EquityEPS = Earnings per shareSource: Factset, J.P. Morgan Asset Management; as of 31 December 2017. The Trust is an actively managed portfolio. Holdings, sector weights, allocations and leverage, as applicable are subject to change without notice. Past performance is not an indication of current and future performance.
We are positioned in long-term consumer services opportunities, less so in the investment-driven economy
Investment opportunities breakdownInvestment opportunities breakdown
*Gearing 9.1%
A focus on ROE and EPS growthA focus on ROE and EPS growth
Others19%
Consumer-facing
financials 16%
Healthcare10%
Technology
Consumption24%
16 | INVESTMENT INVOLVES RISK. PLEASE REFER TO THE OFF ERING DOCUMENT(S) FOR DETAILS, INCLUDING THE RISK FACTORS
Country and sector positions
*Prior to 01/02/16 the benchmark was MSCI Golden Dragon Index (NDR)Source: J.P. Morgan Asset Management. Individual figures may not add up exactly to the total due to rounding. The Trust is an actively managed portfolio. Holdings, sector weights, allocations and leverage, as applicable are subject to change without notice.
JPMorgan Chinese Investment Trust as of 31st December 2017
Active and absolute sector positionsActive and absolute sector positions
Active and absolute country positionsActive and absolute country positions
Benchmark MSCI China (NDR)*
Portfolio Weight (%)
103.3 24.9 20.4 4.2 1.6 -9.1
Portfolio Weight (%)
22.3 10.7 6.5 3.4 2.7 1.5 3.9 3.5 20.6 9.7 1.9 9.0 0.0 34.1 -9.1
Relative to benchmark (%)
13.08.2
2.2 1.2 0.6
0.0 -0.8 -1.1 -2.2 -4.2
0.0 2.0
-4.9 -7.1 -9.1-12-606
1218
ConsumerDiscretionary
HealthCare
Industrials ConsumerStaples
Utilities Materials RealEstate
Energy Financials Banks DiversifiedFinancials
Insurance Telecoms InformationTechnology
Cash
3.3
24.9
-3.4
4.2 1.6
-9.1-20-10
0102030
China A-shares ADRs Hong Kong Taiwan Cash
Relative to benchmark (%)
17 | INVESTMENT INVOLVES RISK. PLEASE REFER TO THE OFF ERING DOCUMENT(S) FOR DETAILS, INCLUDING THE RISK FACTORS
Appendix
18 | INVESTMENT INVOLVES RISK. PLEASE REFER TO THE OFF ERING DOCUMENT(S) FOR DETAILS, INCLUDING THE RISK FACTORS
Trust Benchmark
Number of Holdings 64 152
12-Month Forward Price to Earnings (x) 16.2 13.4
3-5 Year Earnings Per Share Growth (%) 40.5 33.4
Dividend Yield (%) 1.3 1.6
Return on Equity (%) 19.1 16.4
Active Share (%) 70.9
Portfolio characteristics
*Prior to 01/02/16 the benchmark was MSCI Golden Dragon Index (NDR)Source: FactSet, J.P. Morgan Asset Management. The Trust is an actively managed portfolio, holdings, sector weights, allocations and leverage, as applicable are subject to change at the discretion of the Investment Manager without notice.
Market capitalisation (USD)Market capitalisation (USD)
52.1
27.6
17.1
10.8
1.4
62.0
17.813.6
6.5
0.00%
10%
20%
30%
40%
50%
60%
70%
> 30 bn 10 - 30 bn 4 - 10 bn 1 - 4 bn < 1 bn
Trust
Benchmark
JPMorgan Chinese Investment Trust as of 31st December 2017 Benchmark MSCI China (NDR)*
19 | INVESTMENT INVOLVES RISK. PLEASE REFER TO THE OFF ERING DOCUMENT(S) FOR DETAILS, INCLUDING THE RISK FACTORS
Portfolio positions
JPMorgan Chinese Investment Trust as of 31st December 2017
*Prior to 01/02/16 the benchmark was MSCI Golden Dragon Index (NDR)Source: J.P. Morgan Asset Management. The trust is an actively managed portfolio, holdings, sector weights, allocations and leverage, as applicable are subject to change at the discretion of the Investment Manager without notice.
Top 10 holdingsTrust
weight (%)
Tencent 10.9
Alibaba Group 9.5
Ping An Insurance 9.0
China Merchants Bank 4.2
JD.com 3.7
Bank of China 3.4
CNOOC 2.9
AAC Technologies 2.8
China Overseas Land & Investment 2.3
Baidu 2.1
Top 5 overweightsTrust
weight (%)Relative
position (%)
Ping An Insurance 9.0 5.7
China Merchants Bank 4.2 3.3
JD.com 3.7 2.0
AAC Technologies 2.8 2.0
Chongqing Rural Commercial Bank 2.1 2.0
Top 5 underweightsTrust
weight (%)Relative
position (%)
Tencent 10.9 -7.5
China Construction Bank 0.0 -4.8
China Mobile 0.0 -3.9
ICBC 0.0 -3.7
Alibaba 9.5 -2.9
Benchmark MSCI China (NDR)*
20 | INVESTMENT INVOLVES RISK. PLEASE REFER TO THE OFF ERING DOCUMENT(S) FOR DETAILS, INCLUDING THE RISK FACTORS
Important Information
JPMorgan Chinese Investment Trust plc
INVESTMENT OBJECTIVE AND POLICY
The Company aims to provide long term capital growth by investment in companies which are quoted on the stock exchanges of Hong Kong, China and Taiwan or which derive a substantial part of their revenues or profits from these territories. The Company has the ability to use borrowing to gear the portfolio within the range of 10% net cash to 20% geared in normal market conditions.
RISK INFORMATION� Exchange rate changes may cause the value of underlying overseas investments to go down as well as up.� Investments in emerging markets may involve a higher element of risk due to political and economic instability and underdeveloped markets and systems.
Shares may also be traded less frequently than those on established markets. This means that there may be difficulty in both buying and selling shares and individual share prices may be subject to short-term price fluctuations.
� This Trust may use derivatives for investment purposes or for efficient portfolio management.� External factors may cause an entire asset class to decline in value. Prices and values of all shares or all bonds could decline at the same time, or fluctuate
in� response to the performance of individual companies and general market conditions.� This trust may utilise gearing (borrowing) which will exaggerate market movements both up and down.� This trust may also invest in smaller companies which may increase its risk profile. � The share price may trade at a discount to the Net Asset Value of the company.� The single market in which the Trust primarily invests, in this case China, may be subject to particular political and economic risks and, as a result, the trust
may be more volatile than more broadly diversified trusts. � The Trust may invest in China A-Shares through the Shanghai-Hong Kong Stock Connect program which is subject to regulatory change, quota limitations
and also operational constraints which may result in increased counterparty risk.
Please refer to the Company Annual Report & Accounts for more information relating to the Trust.
21 | INVESTMENT INVOLVES RISK. PLEASE REFER TO THE OFF ERING DOCUMENT(S) FOR DETAILS, INCLUDING THE RISK FACTORS
J.P. Morgan Asset Management
This is a marketing communication and as such the views contained herein are not to be taken as an advice or recommendation to buy or sell any investment or interest thereto.Reliance upon information in this material is at the sole discretion of the reader. Any research in this document has been obtained and may have been acted upon by J.P. MorganAsset Management for its own purpose. The results of such research are being made available as additional information and do not necessarily reflect the views of J.P. MorganAsset Management. Any forecasts, figures, opinions, statements of financial market trends or investment techniques and strategies expressed are unless otherwise stated, J.P.Morgan Asset Management’s own at the date of this document. They are considered to be reliable at the time of writing, may not necessarily be all inclusive and are not guaranteedas to accuracy. They may be subject to change without reference or notification to you. It should be noted that the value of investments and the income from them may fluctuate inaccordance with market conditions and taxation agreements and investors may not get back the full amount invested. Changes in exchange rates may have an adverse effect onthe value, price or income of the products or underlying overseas investments. Past performance and yield are not reliable indicators of current and future results. There is noguarantee that any forecast made will come to pass. Furthermore, whilst it is the intention to achieve the investment objective of the investment products, there can be no assurancethat those objectives will be met. J.P. Morgan Asset Management is the brand name for the asset management business of JPMorgan Chase & Co. and its affiliates worldwide. Tothe extent permitted by applicable law, we may record telephone calls and monitor electronic communications to comply with our legal and regulatory obligations and internalpolicies. Personal data will be collected, stored and processed by J.P. Morgan Asset Management in accordance with our EMEA Privacy Policywww.jpmorgan.com/jpmpdf/1320694304816.pdf. Investment is subject to documentation (Investment Disclosure Document, Key Features and Terms and Conditions), copies ofwhich can be obtained free of charge from JPMorgan Asset Management (UK) Limited. This communication is issued by JPMorgan Asset Management (UK) Limited, which isauthorised and regulated in the UK by the Financial Conduct Authority. Registered in England No: 01161446. Registered address: 25 Bank Street, Canary Wharf, London E14 5JP.
0903c02a8203d1f9